Radiomics analysis of non-enhancing lesions after Bevacizumab administration in recurrent glioblastoma

Motivation: Identifying non-contrast-enhancing tumor (nCET) in glioblastoma (GBM) is crucial for surgical treatment. However, T2/FLAIR images are unable to reliably distinguish nCET from vasogenic edema (VE). Goal(s): To develop an MRI-based method to identify nCET via radiomic features on areas where CET transformed to nCET after BEV administration. Approach: Radiomic features were analyzed in an exploratory cohort under BEV treatment (n=24) and a validation cohort who underwent 11C-methionine positron emission tomography (n=23). Results: A combination of three imaging features distinguished nCET from VE (AUC=0.91) with high positive predictive accuracy. Reconstructed MRI images also provided reasonable nCET visualization in newly diagnosed GBMs. Impact: Radiomic features of lesion where CET transformed into nCET after BEV administration may provide valuable information in predicting nCET in GBM.

Authors

Publication Details

Journal
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Published
2025-09-16
DOI
https://doi.org/10.58530/2025/2558
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Radiomics analysis of non-enhancing lesions after Bevacizumab administration in recurrent glioblastoma

Yonehiro Kanemura, Masato Saito, Mishie Ann Tanino, Haruhiko Kishima et al.
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Radiomics and Machine Learning in Medical Imaging
article

Radiomics analysis of non-enhancing lesions after Bevacizumab administration in recurrent glioblastoma

Yonehiro Kanemura, Masato Saito, Mishie Ann Tanino, Haruhiko Kishima, Satoru Hiroshima, Nobuyuki Mitsui, Yoshiko Okita, Hideyuki Arita, Manabu Kinoshita, Takeshi Shimizu, Hirotaka Sato, Takahiro Sanada
article en

Abstract

Motivation: Identifying non-contrast-enhancing tumor (nCET) in glioblastoma (GBM) is crucial for surgical treatment. However, T2/FLAIR images are unable to reliably distinguish nCET from vasogenic edema (VE). Goal(s): To develop an MRI-based method to identify nCET via radiomic features on areas where CET transformed to nCET after BEV administration. Approach: Radiomic features were analyzed in an exploratory cohort under BEV treatment (n=24) and a validation cohort who underwent 11C-methionine positron emission tomography (n=23). Results: A combination of three imaging features distinguished nCET from VE (AUC=0.91) with high positive predictive accuracy. Reconstructed MRI images also provided reasonable nCET visualization in newly diagnosed GBMs. Impact: Radiomic features of lesion where CET transformed into nCET after BEV administration may provide valuable information in predicting nCET in GBM.

Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Openalex Percentile: Top 65%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.